1.7 USD
-0.06 (-3.41%)
ChartMill assigns a Buy % Consensus number of 79% to JSPR. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 12.92. This target is 660% above the current price.
JSPR was analyzed by 15 analysts. The buy percentage consensus is at 79. So analysts seem to be have mildly positive about JSPR.
In the previous month the buy percentage consensus was at a similar level.
JSPR was analyzed by 15 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-11-11 | RBC Capital | Maintains | Sector Perform -> Sector Perform |
| 2025-09-22 | BTIG | Maintains | Buy -> Buy |
| 2025-09-22 | JMP Securities | Maintains | Market Outperform -> Market Outperform |
| 2025-09-22 | Evercore ISI Group | Maintains | Outperform -> Outperform |
| 2025-08-15 | UBS | Maintains | Buy -> Buy |
| 2025-07-08 | BMO Capital | Downgrade | Outperform -> Market Perform |
| 2025-07-08 | JMP Securities | Maintains | Market Outperform -> Market Outperform |
| 2025-07-08 | Evercore ISI Group | Maintains | Outperform -> Outperform |
| 2025-07-07 | Cantor Fitzgerald | Downgrade | Overweight -> Neutral |
| 2025-07-07 | William Blair | Downgrade | Outperform -> Market Perform |
| 2025-07-07 | BTIG | Maintains | Buy -> Buy |
| 2025-07-07 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-05-15 | Oppenheimer | Maintains | Outperform -> Outperform |
| 2025-05-13 | UBS | Maintains | Buy -> Buy |
| 2025-03-11 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-02-13 | UBS | Initiate | Buy |
| 2025-01-10 | JMP Securities | Reiterate | Market Outperform -> Market Outperform |
| 2025-01-10 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-01-09 | RBC Capital | Maintains | Outperform -> Outperform |
| 2025-01-06 | JMP Securities | Maintains | Market Outperform -> Market Outperform |
| 2024-12-23 | RBC Capital | Reiterate | Outperform -> Outperform |
| 2024-12-06 | BMO Capital | Initiate | Outperform |
| 2024-10-24 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-10-15 | JMP Securities | Reiterate | Market Outperform -> Market Outperform |
| 2024-10-15 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-09-27 | JMP Securities | Reiterate | Market Outperform -> Market Outperform |
| 2024-09-09 | Cantor Fitzgerald | Reiterate | Overweight |
| 2024-09-09 | JMP Securities | Initiate | Market Outperform |
| 2024-08-26 | Evercore ISI Group | Maintains | Outperform -> Outperform |
| 2024-08-14 | RBC Capital | Maintains | Outperform -> Outperform |
JASPER THERAPEUTICS INC / JSPR FAQ
What is the average price target for JASPER THERAPEUTICS INC (JSPR) stock?
15 analysts have analysed JSPR and the average price target is 12.92 USD. This implies a price increase of 660% is expected in the next year compared to the current price of 1.7.
What is the consensus rating for JSPR stock?
The consensus rating for JASPER THERAPEUTICS INC (JSPR) is 78.6667 / 100 . This indicates that analysts generally have a positive outlook on the stock.
How many analysts cover JASPER THERAPEUTICS INC (JSPR) stock?
The number of analysts covering JASPER THERAPEUTICS INC (JSPR) is 15.